Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...
In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...
Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...
The Federal Trade Commission (FTC) has sued the top three ... system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the ...
No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...
The companies are accused by the Federal Trade Commission of engaging in anticompetitive practices that spur price increases. This is not the first time the cost of insulin has been under the ...
High insulin prices have been a hot topic in ... “The Biden administration, Congress, the Federal Trade Commission, and others need to do everything in their power to address the anti ...
Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...
“Notably, glucose values vary over a narrow range (from approximately 2 to 20-30 mM [36 mg/dL to 360-540 mg/dL] in people with diabetes), so a rather steep change in insulin bioactivity must be ...
Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Gov. Brian Kemp, though, vetoed a related bill that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback